OFATUMUMAB WITH IVAC FOR DLBCL PATIENTS WHO FAILED R‐CHOP AND WERE NOT CANDIDATES FOR HIGH‐DOSE THERAPY AND ASCT ‐ PHASE 2 TRIAL OF THE POLISH LYMPHOMA RESEARCH GROUP (PLRG‐8). (12th June 2019)

• Record Type: Journal Article
• Authors: Paszkiewicz‐Kozik, E.; Michalski, W.; Taszner, M.; Knopińska‐Posłuszny, W.; Mordak‐Domagała, M.; Najda, J.; Borawska, A.; Romejko‐Jarosińska, J.; Chełstowska, M.; Świerkowska, M.; Dąbrowska‐Iwanicka, A.; Malenda, A.; Druzd‐Sitek, A.; Konecki, R.; Kuniega, B.; Osowiecki, M.; Ostrowska, B.; Szpila, T.; Domańska‐Czyż, K.; Szymański, M.; Targoński, Ł.; Poplawska, L.; Kotarska, M.; Giebel, S.; Lange, A.; Pluta, A.; Warzocha, K.; Zaucha, J.; Rymkiewicz, G.; Walewski, J.
• Is Part Of: Hematological oncology. Volume 37(2019)Supplement 2
• Page Start: 436
• Page End: 437
• Publication Date: 2019-06-12
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.111_2631
• Languages: English
• ISSNs: 0278-0232